Drug
Betamethasone Valerate clinical trials
A product of Betamethasone; its studies count on that page too.
- studies test it
- 9
- open now
- 3
- in phase 3
- 2
- first study started
- 2004
Keep track of what changes. Save the Betamethasone Valerate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 4
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 7
Cairo University (2) · ACO Hud Nordic AB (2) · Assiut University (2) · Wei-Che Ko (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · Baylor College of Medicine (1)
Often tested with
Tested in the same studies.
Urea (2) · Dupilumab (1) · Adalimumab (1) · Ustekinumab (1) · Guselkumab (1) · Canakinumab (1) · Sarilumab (1) · Triamcinolone Acetonide (1)
Studies
Open first, then newest update. How each study uses Betamethasone Valerate is read from its arms, and is right about nine times in ten.
Testing it · 9
- Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot StudyRecruitingPhase 4Baylor College of MedicineNCT07508124Written as betamethasone valerate 0.1% cream
- Evaluation the Topical Apremilast Nanoformulation in Treatment of Localized Plaque PsoriasisNot yet recruitingNot applicableAssiut UniversityNCT07366268Written as betamethasone valerate 0.1% cream
- Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex ChronicusNot yet recruitingNot applicableCairo UniversityNCT06267066Written as Betamethasone Valerate 0.1% Cream
- Using a Contact Dermatitis Model With Biologic Medications to Study Skin InflammationActive, not recruitingPhase 2/3Wei-Che KoNCT05535738Written as Betamethasone Valerate
- Skin bioMARkers for Atopic Eczema Therapy EvaluationCompletedPhase 2Sheffield Teaching Hospitals NHS Foundation TrustNCT04194814Written as betamethasone valerate 0.1% cream
- Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer PatientsCompletedPhase 4Cairo UniversityNCT05285943Written as Betamethasone Valerate Cream
- Excimer Laser With Topical Agents in Psoriasis VulgarisStatus unknownPhase 4Assiut UniversityNCT05555797Written as Betamethasone Valerate
- A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand EczemaCompletedPhase 4ACO Hud Nordic ABNCT00576550Written as betamethasone valerate
- Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a MoisturiserCompletedPhase 3ACO Hud Nordic ABNCT00576238Written as betamethasone valerate
Given in every arm · 3 — Betamethasone Valerate is usual care beside what is tested
- Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced ParonychiaRecruitingPhase 3Queen Mary Hospital, Hong KongNCT06643416Written as Betamethasone valerate 0.1% cream
- Study of Safety and Efficacy of Topical GSK2981278 Ointment in Plaque PsoriasisCompletedPhase 1GlaxoSmithKlineNCT02548052Written as Betamethasone valerate 0.1%
- SHP-141C in Plaque Type PsoriasisCompletedPhase 1TetraLogic PharmaceuticalsNCT01646567Written as Betamethasone Valerate
As the comparator · 8 — what is tested is compared with Betamethasone Valerate
- Efficacy and Safety of Timolol for TKI Induced ParonychiaRecruitingPhase 3Queen Mary Hospital, Hong KongNCT06140186Written as Betamethasone Valerate
- Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.Not yet recruitingPhase 1Assiut UniversityNCT06087796Written as Betamethasone Valerate 0.1% Cream
- Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque PsoriasisCompletedPhase 1LEO PharmaNCT03669757Written as 0.1% betamethasone valerate ointment (class III steroid)
- Safety and Efficacy of CD10367 in Psoriasis VulgarisCompletedPhase 2Galderma R&DNCT03025282Written as Betneval ointment - Non-desquamated zone
- Comparative Effect of Nigella Sativa and Conventional Management for OSMFCompletedPhase 3Ziauddin UniversityNCT04476420Written as Betamethasone Valerate
- Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen PlanusCompletedPhase 4Ain Shams UniversityNCT02443311Written as Betamethasone 17-valerate 0.1% cream
- Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive DermatosisStatus unknownPhase 3Mantecorp Industria Quimica e Farmaceutica Ltd.NCT01011621Written as 0.1% betamethasone valerate cream
- Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus ErythematosusCompletedNot applicableShahid Beheshti University of Medical SciencesNCT00608673Written as betamethasone valerate 0.1% cream
Codes
What other systems call Betamethasone Valerate · ClinicalTrials.gg INT007070
- MeSH (NLM) D001624Betamethasone ValerateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 9IFA5XM7R2BETAMETHASONE VALERATEConfirmed FDA, NLM, Wikidata
- RxNorm 227897Confirmed FDA, Wikidata
- Wikidata Q6445931betamethasone valerateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47962Betamethasone ValerateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001624 | Betamethasone Valerate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 9IFA5XM7R2 | BETAMETHASONE VALERATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 227897 | — | Confirmed FDA, Wikidata |
| Wikidata | Q6445931 | betamethasone valerate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47962 | Betamethasone Valerate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.